Saracco et al. "Hepatitis C virus markers in patients withlong-term biochemical and histological remission of chronic hepatitis" Liver 14:65-70, 1994. |
Bradley, et al., "Molecular characterization of hepatitis C and E viruses," Arch. Virol. 7:1-14 (1993). |
Cerino and Mondelli, "Identification of an Immunodominant B Cell Epitope on the Hepatitis C Virus Nonstructural Region Defined by Human Monoclonal Antibodies," The Journal of Immunology 147:2692-2696 (Oct. 15, 1991). |
Chien, et al., "Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: Reevaluation of the role of HCV in liver disease," Proc. Natl. Acad. Sci. USA 89:10011-10015 (Nov. 1992). |
Kuo, et al., "An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis," Science 244:362-364 (Apr. 1989). |
Simmonds, et al., "Mapping of Serotype-Specific, Immunodominant Epitopes in the NS-4 Region of Hepatitis C Virus (HCV): Use of Type-Specific Peptides to Serologically Differentiate Infections with HCV Types 1, 2, and 3," Journal of Clinical Microbiology 31:1493-1503 (Jun. 1993). |
Wong, et al., "Longitudinal Analysis of the Humoral Immune Response to Human Immunodeficiency Virus Type 1 (HIV-1) gp160 Epitopes in Rapidly Progressing and Nonprogressing HIV-1-Infected Subjects," The Journal of Infectious Diseases 1993 168:1523-1527 (Dec. 1993). |
Xing et al., "Second Generation Anti-MUC1 Peptide Monoclonal Antibodies," Cancer Research 52:2310-2317 (Apr. 15, 1992). |